OSCeauN

Delivery system established for oral and inhalation.

Efficacy well established for pathogens – bacteria, virus, fungal

No likelihood of resistance. Succesful study in URT – around 80% efficacy. 3 Sepsis patinets cured of infection in 3 days.

Technology:
  • Infection prevention
  • Antimicrobial compounds

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental

Development stage:
  • Validation
  • Market entry

Organization:
  • Company

Partnering:
  • License, Joint Venture

Development and manufacture of bio-identical active anti-microbials.

Potential in animal and humans, also for clean air and agriculture.


What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!